Kandulski, Arne

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial

Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet

Hepatocellular Carcinoma Treatment and PrognosisCancer Immunotherapy and Biomarkers

Cited by 545

Proton-pump inhibitors: understanding the complications and risks

Malfertheiner, P., Kandulski, A., & Venerito, M. (2017) · Nature Reviews Gastroenterology & Hepatology

Gastroesophageal reflux and treatmentsHelicobacter pylori-related gastroenterology studies

Cited by 297

Gastroesophageal reflux disease–from reflux episodes to mucosal inflammation

Kandulski, A., & Malfertheiner, P. (2012) · Nature Reviews Gastroenterology & Hepatology

Gastroesophageal reflux and treatmentsEsophageal Cancer Research and Treatment

Cited by 76